3rd Quarter - Report
MAYO CLINIC for MAYO CLINIC
Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Alcohol and Drug Abuse ALC
Opioid Epidemic
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER MALLARD | — |
Health Issues HCR
Affordable Care Act Repeal and Replace; American Health Care Act (H.R. 1628); Telemedicine;
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER MALLARD | Director, Federal Government Relations |
Medicare/Medicaid MMM
Medicare physicians payments; Medicare hospital payments; Medicare clinical lab payments; Quality Issues; Telemedicine; Drug Pricing
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER MALLARD | Director, Federal Government Relations |
Medical/Disease Research/Clinical Labs MED
Lab payments (PAMA); Research Funding; Regulatory Relief
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER MALLARD | Director, Federal Government Relations |
Science/Technology SCI
NIH Regulatory Relief; Telemedicine technology; New Diagnostic Tests; Precision Medicine
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER MALLARD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.